Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease

Type 2 diabetes mellitus is a risk factor for progression of liver fibrosis in middle‐aged patients with nonalcoholic fatty liver disease

(2019) Toshifumi Tada et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non-alcoholic fatty liver disease: A growing public health problem in Turkey

(2019) Eda Kaya et al.   Turkish Journal of Gastroenterology

Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

(2018) Zobair Younossi et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

(2017) Wenjie Dai et al.   MEDICINE

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance

(2015) Per Stål   WORLD JOURNAL OF GASTROENTEROLOGY

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

(2013) Stuart McPherson et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: The Edinburgh type 2 diabetes study

(2013) Joanne R. Morling et al.   JOURNAL OF HEPATOLOGY

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

Endpoints and clinical trial design for nonalcoholic steatohepatitis

(2011) Arun J. Sanyal et al.   HEPATOLOGY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

(2008) Mireen Friedrich–Rust et al.   GASTROENTEROLOGY